Emulate Inc. closes $82M Series E to fund expansion of ‘organ-on-a-chip’ products
TechCrunch
SEPTEMBER 7, 2021
a biotech company focused on developing “organ-on-a-chip” technology, closed an $82 million Series E round on Tuesday. An organ-on-a-chip is pretty much exactly what it sounds like: it’s a recreation of a human organ (or system of human organs) scaled down into a tiny piece of hardware about the size of a AA battery. Emulate Inc.,
Let's personalize your content